Cue Biopharma appoints Pasha Sarraf to board of directors

Cue Biopharma, Inc.

Pasha Sarraf appointed to board on March 10, 2025.
Granted option to purchase 48,800 shares vesting over three years.
Compensation per Company's Director Compensation Policy.
Entered standard indemnification agreement for director service.
No arrangements or transactions between Sarraf and Company.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Pasha Sarraf

member of the board of directors

CUE · Cue Biopharma, Inc.

Effective: 2025-03-10
Filed: March 12, 2025, 7:59 PM ET

On March 10, 2025, Pasha Sarraf was appointed to the board of directors (the “Board”) of Cue Biopharma, Inc. (the “Company”), following the recommendation of the Corporate Governance and Nominating Committee of the Board.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Pasha Sarraf was appointed as member of the board of directors at Cue Biopharma, Inc..

Action: appointed
Role: member of the board of directors

Exact text from the filing

On March 10, 2025, Pasha Sarraf was appointed to the board of directors (the “Board”) of Cue Biopharma, Inc. (the “Company”), following the recommendation of the Corporate Governance and Nominating Committee of the Board.

View on SEC.gov

Cue Biopharma, Inc. filing history →

Source: SEC EDGAR

accession 0000950170-25-037885

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.